The role of patient organisations – Genethon

In Orphan Drug Congress by Cameron

Frederic Revah, Director General & Chief Executive Officer at Genethon gives his presentation: ‘The role of patient organisations in funding and managing R&D for rare disease research and orphan drug development’ at the World Orphan Drug Congress 2013.

The annual World Orphan Drug Congress Europe is the region’s largest event dedicated to dedicated to scientific, commercialisation and business development: an exhibition, a strategic keynote conference and real life case studies.